期刊
JOURNAL OF LEUKOCYTE BIOLOGY
卷 102, 期 3, 页码 657-675出版社
WILEY
DOI: 10.1189/jlb.2MR0317-105R
关键词
motheaten; inflammation; autoimmunity; tyrosine phosphatase; Ptpn6
资金
- U.S. National Institutes of Health [RO1AI65495, RO1AI68150, RO1AI113272]
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113272, R01AI065495, R01AI068150] Funding Source: NIH RePORTER
The motheaten mouse was first described in 1975 as a model of systemic inflammation and autoimmunity, as a result of immune system dysregulation. The phenotype was later ascribed to mutations in the cytoplasmic tyrosine phosphatase Shp1. This phosphatase is expressed widely throughout the hematopoietic system and has been shown to impact a multitude of cell signaling pathways. The determination of which cell types contribute to the different aspects of the phenotype caused by global Shp1 loss or mutation and which pathways within these cell types are regulated by Shp1 is important to further our understanding of immune system regulation. In this review, we focus on the role of Shp1 in myeloid cells and how its dysregulation affects immune function, which can impact human disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据